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Abstract
Objective: To assess the performance of short nanorough implants (8.5 mm in length) provided
with either a platform-matched or a platform-switched implant–abutment connection, placed in
the resorbed posterior region of partially dentate patients.
Materials and Methods: A total of 149 implants with a dual-acid surface and a discrete crystalline
deposition of nanometer-sized CaP particles, with either a platform-matched (control) or a
platform-switched implant–abutment connection (test) were placed (randomly assigned) in 92
patients. Follow-up visits were conducted 1 month and 1 year after placing the implant crown.
Outcome measures were implant survival, radiographic peri-implant bone loss, clinical parameters,
and patient’s satisfaction.
Results: One year after loading, 6 of 76 implants in the control group (survival 92.1%) and 3 of 73
implants in the test group (survival 95.9%) were lost (P = 0.33). Radiographic bone loss around test
implants (0.50 ± 0.53 mm) was significantly less than around control implants (0.74 ± 0.61 mm;
P < 0.005). With regard to implant survival, clinical parameters, and patient’s satisfaction, no
significant differences were observed between test and control group.
Conclusions: For teeth replacements in the resorbed posterior region of partially dentate patients,
short implants with a platform-switched implant–abutment connection showed significantly less
peri-implant bone loss after 1 year in function, while implant survival, clinical parameters, and
patient’s satisfaction were independent of the implant–abutment connection design.
Short implants (<10 mm in length) are
increasingly used for the prosthetic rehabili-
tation of the extremely resorbed posterior
zone of partially edentulous patients. The
findings from the systematic review of Tell-
eman et al. (2011a) add to the growing evi-
dence that short implants can be successfully
placed in the partially edentulous patients,
though with an increasing survival rate per
implant length.
In the past, short implants have been asso-
ciated with lower survival rates (Lee et al.
2005; Romeo et al. 2010). Compared with
longer implants with a comparable diameter,
there is less bone to implant contact when
short implants are used, simply because there
is less implant surface. Furthermore, short
implants are mostly placed in the posterior
zone where the quality of the alveolar bone
in this region is relatively poor, especially in
the maxilla (type III or IV, Lekholm & Zarb
1985).
To avoid the use of short implants, the
extremely resorbed bone can be augmented
using a bone grafting technique. This modifi-
cation in the patient’s anatomy allows for
the placement of longer implants, but is
accompanied by an extra surgical interven-
tion, greater patient’s morbidity, higher costs,
and a longer treatment period. Esposito et al.
(2010) concluded from their systematic
review on augmentation procedures of the
maxillary sinus: “Short implants (5–8 mm)
may be as effective and cause fewer compli-
cations than longer implants placed using a
more complex technique.” And from their
systematic review on horizontal and vertical
bone augmentation techniques for dental
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implant treatment, they concluded (Esposito
et al. 2009): “Short implants appear to be a
better alternative to vertical bone grafting of
resorbed mandibles. Complications, especially
for vertical augmentation, are common.”
New developments of the various implant
systems, especially innovations with regard
to the surface microtopography and chemis-
try, have resulted in higher survival rates of
short implants (Hagi et al. 2004; Renouard &
Nisand 2006; Kotsovilis et al. 2009; Romeo
et al. 2010). Nowadays, there is considerable
interest in whether nanometer-sized irregu-
larities on the implant surface affect the bone
response as it already has been shown that
implant surface roughness on a micrometer
level does influence cell and tissue response
(Shalabi et al. 2006; Lang & Jepsen 2009;
Wennerberg & Albrektsson 2009a,b). In 2008,
Meirelles et al. reported a study in which
they developed an experiment in which
microroughness was controlled and demon-
strated that nanometer-sized hydroxyapatite
particles (10 nm) on the implant surface
indeed resulted in a stronger bone response.
Furthermore, it was shown that nanorough-
ness and calcium phosphate (CaP) particles
on implant surfaces also were accompanied
by earlier peri-implant bone formation, pre-
sumably related to increased activation of
platelets (Park et al. 2001; Kikuchi et al.
2005; Arvidsson et al. 2007; Mendes et al.
2007). It has been postulated that these plate-
lets may play an initiating role in the process
called contact osteogenesis; activated plate-
lets stimulate osteogenetic cells to migrate to
the surface of the implant. On the implant
surface, these osteogenic cells differentiate
into osteoblasts and start depositing new bone
(Davies 2003, 2007). Therefore, it has been
postulated that especially in more challenging
implants cases, as short implants placed in
poor quality bone, this acceleration of early
peri-implant bone healing might result in
higher survival rates. Indeed, histologic and
histomorphometric human studies on
implants with nanometer-sized deposition of
CaP on their surface showed acceleration of
early peri-implant bone healing (Goene´ et al.
2007, Orsini et al. 2007; Telleman et al. 2010).
Another new development in the implant
design on the macrolevel is the concept of
platform switching, that is, placing a smaller-
diameter abutment on a wider-diameter
implant. The mismatch between the implant
and abutment creates a circumferential hori-
zontal difference in dimension between the
implant and the abutment restorative plat-
form. Early results of platform-switched
implants showed radiographically no loss of
crestal bone levels, contrary to standard plat-
form-matched implants (Wagenberg & Froum
2010). Several hypotheses have been posed to
explain the rationale behind the concept of
platform switching for marginal bone preser-
vation. The biomechanical hypothesis is that
by platform switching the stress-concentra-
tion zone (from the forces of occlusal loading)
is directed from the crestal bone–implant
interface to the axis of the implant and so
greatly reduces the stress level in the cervical
bone area (Maeda et al. 2007). Other studies
showed that placing the implant–abutment
connection below the crestal bone level may
cause vertical bone resorption to re-establish
the biologic width (Hermann et al. 2001;
Cochran et al. 2009). Following this theory,
platform switching medializes the microgap
between implant and abutment and the loca-
tion and the biologic width. Another hypoth-
esis concerned the role of inflammatory cell
infiltrate at the implant–abutment connec-
tion. The presence of peri-implant microbiota
was suggested to influence crestal bone
resorption by maintaining the inflammatory
cell infiltrate within the implant–abutment
connection (Ericsson et al. 1995, 1996; Brog-
gini et al. 2006).
As was reported in the review on short
implants (Telleman et al. 2011a), the survival
rates are not yet optimal of the shortest
implants, implants placed in the maxilla, or
implants placed in patients with a smoking
habit. The nanorough surface and the concept
of platform switching might lead to higher
survival rates and less peri-implant bone loss.
To our knowledge, no study has been reported
about the effect of nanoroughness through the
deposition of nanometer-sized CaP particles
on the survival rates of short implants and the
effect of platform switching on peri-implant
bone-level changes around short implants
placed in the posterior region of partially den-
tate patients. Therefore, the aim of this study
was to compare the outcome of short nano-
rough implants (8.5 mm in length), provided
with either a platform-matched implant–abut-
ment connection or a platform-switched
implant–abutment connection, placed in the




Partially edentulous patients referred to the
Department of Oral and Maxillofacial Surgery
of the University Medical Center Groningen
for implant therapy in the posterior region
were considered for inclusion if they fulfilled
the following criteria:
• at least 18 years of age;
• capable of understanding and giving
informed consent;
• one or more missing teeth being a premo-
lar and/or molar in the maxilla or mandi-
ble;
• at the place of the future implant a maxi-
mum of 10mm bone in vertical dimen-
sion and a minimum of 5mm bone in
horizontal dimension available.
Exclusion criteria were as follows:
• medical and/or general contraindications
for the surgical procedures (ASA score 
III (Smeets et al. 1998));
• presence of active clinical periodontal dis-
ease in the dentition as expressed by
probing pocket depths  5 mm and
bleeding on probing;
• presence of peri-apical lesions or any
other abnormalities or infections at the
implant site as determined on a radio-
graph;
• smoking;
• a history of radiotherapy to the head and
neck region.
Study design
This randomized clinical trial was approved
by the Medical Ethical Committee of the
University Medical Center Groningen. Before
enrollment, written and verbal information
was given to the patients and written
informed consent was obtained.
Two different implant–abutment connec-
tions were studied. The platform-switched
implants (NanoTite Certain Prevail, Biomet
3i, Palm Beach Gardens, FL, USA) used in
the test group had a horizontal implant
–abutment diameter difference of 0.35 and
0.40 mm (for implants with a diameter of 4
and 5 mm, respectively). In a vertical dimen-
sion, the implant–abutment connection lies
0.09 and 0.11 mm (for implants with a diam-
eter of 4 and 5 mm, respectively) above the
level of implant placement (Fig. 1a). The test
implants were compared with the control
implants (NanoTite XP Certain, Biomet 3i).
The latter type of implants matches the plat-
form-switched implants the most except for
the implant–abutment connection (Fig. 1b).
The implant types used, which both were
made of the same titanium alloy, had a dual-
acid-etched (using hydrochloric and sulfuric
acids) surface with a discrete crystalline
deposition of nanometer-sized CaP particles.
The CaP deposit on the dual-acid-etched
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(DAE) implants did not form a confluent
layer; the CaP particles (20–100 nm in size)
are deposited in the peaks and valleys of the
DAE surface, and occupy approximately 50%
of the surface. The average roughness of this
surface is 0.5 lm, which is considered as
minimally rough (Wennerberg & Albrektsson
2010). The developed surface area ratio, a
measurement that provides information
regarding surface enlargement if a given sur-
face is flattened out, is 40% (Wennerberg &
Albrektsson 2010). Both implant types (test
and control) had an extended platform and all
implants were 8.5 mm in length.
A specifically designed locked computer
software program was used to randomly
assign patients to one of the two study
groups. Randomization by minimization (Alt-
man 1991) was used to balance the possible
prognostic variables between the two treat-
ment groups. Minimization was used for the
variables gender, age ( 50, >50 years), loca-
tion of the implant site (maxilla, mandible),
tooth or teeth to replace (premolar, molar,
premolar & molar), and number of implants
to be placed (1, 2 or more). The surgeon who
inserted the implants was informed about
the allocation result on the day of surgery,
before implant surgery was started. The
prosthodontist was informed about the allo-
cation result before the impression of the
healing abutment was made. Patients were
not informed about the allocation result.
Interventions
All patients were treated at the Department
of Oral and Maxillofacial Surgery of the Uni-
versity Medical Center Groningen. The
implants were placed in healed sites, that is,
at least 3–4 months after tooth removal
allowing the extraction site to have healed.
Implants were placed and restored according
to the protocol described in detail by Tell-
eman et al. (2011b). Briefly, an incision was
made on top of the alveolar crest and a surgi-
cal template was used. The implant shoulder
was placed at bone level, both mesial and dis-
tal even with the alveolar crest, if necessary
the bone was flattened. The distance between
the implant and the neighboring teeth was at
least 1.5 mm, and the distance between two
implants was at least 3 mm. On this
implant, a coded healing abutment (Encode®,
Biomet 3i) with a height of 4 mm was placed
to develop an emergence profile. Next, if any,
implant dehiscences or fenestrations at the
buccal side of the implant were covered with
autogenous bone chips collected during
implant bed preparation and anorganic bovine
boss (Bio-oss®, Geistlich Pharma AG, Wolhu-
sen, Switzerland) overlaid with a collagen
membrane (Bio-Gide®, Geistlich Pharma
AG). Finally, the wound was closed with
sutures (Vicryl® 3-0, Johnson & Johnson,
Brunswick, NJ, USA). Two weeks following
implant surgery the sutures were removed.
Three months after implant placement, seat-
ing of the healing abutment was evaluated
and impressions were made. The healing
abutment was scanned from the cast and an
individualized abutment was milled. The
abutment was placed with 20 Ncm and the
metal-ceramic crown was cemented (GC Fuji
1, GC Europe NV, Leuven, Belgium).
A single experienced oral and maxillofacial
surgeon performed all surgical procedures.
Six experienced prosthodontics performed the
prosthetic procedure. The individual cad-cam
made abutments were made by the implant
manufactory (Encode®, Biomet 3i). One den-
tal technician fabricated the metal-ceramic
crowns.
Outcome measures
The primary outcome measure was the mean
peri-implant bone-level change (mesial and
distal sides combined) from the time of
implant placement (baseline) to 1 year after
placing the crown on the implant; which is
16 months after placing the implant (T16m) as
measured on standardized digital radiographs.
Secondary outcome measures were implant
survival, changes in marginal soft tissue level
of the implant and the neighboring teeth, and
patient’s satisfaction. One and the same
examiner performed all measurements. To
assess the reliability of the radiographic
examination, this examiner was assisted by a
second examiner. The operationalization of
the variables is described below.
Radiographic assessments
Before implant placement (Tpre), directly after
implant placement (baseline or T0m),
1 month after the placement of the implant
crown, which is 5 months after placing
the implant (T5m), and 1 year after placing
the implant crown, which is 16 months after
placing the implant (T16m), digital peri-apical
radiographs (Planmeca Intra X-ray unit,
Planmeca, Helsinki, Finland) were taken
using a paralleling technique. For each
patient, an individualized X-ray holder was
made to standardize the peri-apical radio-
graphs (Fig. 2). The radiograph taken before
implant placement was only used for diag-
nostic reasons to detect any infection of
abnormality. The radiographs were analyzed
using specially designed computer software
to perform linear measurements on the digi-
tal radiographs (in cooperation with the
Department of Biomedical Engineering,
University Medical Center Groningen, The
Netherlands). The calibration was carried out
in the vertical plane for each radiograph, by
using the known distance of several threads.
This calibration ensured a correct measure-
ment (Sewerin 1990). To assess the reliability
of the radiographic examination, 30 radio-
graphs of 20 patients (10 from each study
group) were assessed by two examiners. The
interobserver agreement was tested on 120
measurements (30 radiographs 9 20 patients
9 2 (mesial, distal) bone level assessments)
(a)
(b)
Figure 1. (a). Dental radiograph of a test implant (Nano-
Tite Certain Prevail, Biomet 3i). (b) Dental radiograph
of a control implant (NanoTite XP Certain, Biomet 3i).
Figure 2. Individualized X-ray holder to make standard-
ized intra-oral dental radiographs.
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of the first examiner and 120 measurements
of the second examiner.
Clinical assessments
Preoperatively (Tpre), 1 month (T5m) and
1 year (T16m) after the placement of the
implant crowns, the soft tissue around the
implants and their neighboring teeth were
clinically examined using the following clini-
cal parameters:
• Assessment of plaque accumulation with
the modified Plaque Index (Mombelli
et al. 1987);
• Assessment of bleeding tendency with
the modified Sulcus Bleeding Index
(Mombelli et al. 1987);
• Assessment of peri-implant inflammation
with the Gingival Index (Lo¨e & Silness
1963);
• Presence of dental calculus;
• Sulcus probing pocket depth: measured to
the nearest millimeter using a manual
periodontal probe (Williams Color-Coded
Probe; Hu-Friedy, Chicago, IL, USA).
Before the incision was made, the mucosa
thickness was assessed by applying a peri-
odontal probe through the mucosa at the spot
where the implant would be placed.
Patient’s satisfaction
Patient’s satisfaction was assessed using a
self-administered questionnaire to be com-
pleted at Tpre and T5m. The questionnaire
comprised of questions or statements that
could be answered on a five-point rating scale
ranging from “very dissatisfied” and “not in
agreement” (score 1) to “very satisfied” and
“in agreement” (score 5). Topics were esthet-
ics, function and treatment procedure. Fur-
thermore, patients were asked to mark their
overall satisfaction about their mouth in
which they missed teeth, which were
replaced by implants, at Tpre and T5m on a
10-point rating scale from 0 to 10, in which
10 is the highest score.
Statistical analysis
Sample size was calculated using G*power
version 3.1 (Faul et al. 2009). As there were
no data in the literature of the mean
marginal bone loss of short control implants
with the platform-matched implant–abut-
ment connection, it was assumed that a
mean marginal bone loss of 1.0 ± 0.5 mm
would occur, from implant placement to
16 months thereafter, as the maximum mar-
ginal bone loss is seen up to 1.5 mm to the
first implant thread. We considered 0.5 mm
of radiographic marginal bone loss as a clini-
cally relevant difference between study
groups, with an expected standard deviation
of 0.75 mm. With a one-sided significance
level of 5% and a power of 95%, a minimum
of 36 patients per group was required, if one
implant per patient was placed. A total of 72
patients for both groups would be needed; the
total number of patients was set to at least
80 to deal with withdrawal.
To assess the interobserver agreement for
the continuous variables of the peri-implant
bone-level changes (scored on peri-apical
radiographs), two-way random models were
used to calculate the interclass correlation
coefficient.
To see whether the data were normally dis-
tributed, the frequency distribution was plot-
ted in a histogram. To test whether the
result from the frequency analyses differed
significantly from a normal distribution,
Kolmogorov–Smirnov and Shapiro–Wilk tests
were performed. As the variables were not
normally distributed, Mann–Whitney tests
were used for between groups comparisons.
Fisher’s exact test was used to assess
whether there was a difference in implant
survival rate. Pearson’s correlation coeffi-
cients were used to assess whether the
observed peri-implant bone loss was depen-
dent on the possible confounders numbers of
implants placed, implant location, implant
diameter, result of the microbiological cul-
ture, mucosal thickness before placement,
and type of bone (Lekholm & Zarb 1985).
Wilcoxon signed rank tests were used for
changes in patient’s satisfaction before and
after the implant treatment.
In all analyses, a significance level of
P < 0.05 was chosen. Data were analyzed using
the Statistical Package for Social Sciences
(version 16.0, SPSS Inc, Chicago, IL, USA).
Results
Patients
Between February 2006 and December 2009,
a total of 92 (47 control group, 45 test group)
patients were included in this trial. Baseline
patients and treatment characteristics are
listed in Table 1. There was 1 dropout; a
patient did not react on any kind of commu-
nication to invite the patient for follow-up;
thus, data from 91 patients were available for
the intention-to-treat analysis.
Peri-implant bone-level changes
The intraclass correlation coefficient for aver-
age measures was 0.867 for the radiographic
interobserver agreement (Cronbach’s
alpha = 0.867), which can be interpreted as
almost perfect agreement (Viera & Garrett
2005).
Fig. 3 shows the frequency distributions of
the mean peri-implant bone loss of the con-
trol group with the platform-matched
implant–abutment connection and the test
group with the platform-switched implants.
Overall, mean peri-implant bone loss was
significantly less around platform-switched
implants than around implants with plat-
form-matched implant–abutment connec-
tions, both 1 month and 1 year after placing
the crown (Table 2). However, when compar-
ing peri-implant bone loss in cases provided
with one implant, no difference in peri-
implant bone loss was observed; when 2 or
more adjacent platform-switched implants
were placed, bone loss was significantly less
comparing to platform-matched implants,
1 month and 1 year after placing the crown
(Table 2). The effect size of the total group of
implants was 0.39, of single implant placed
0 and of 2 or more adjacent implants 0.45,
respectively.
Implant survival
Six of 76 implants in the control group (plat-
form-matched; implant survival rate 92.1%)
were lost; 3 implants before loading
and 3 implants 1–6 months after loading.
Three of 73 implants in the test group (plat-
form-switched implant–abutment connec-
tion; implant survival rate 95.9%) were lost;
all three implants were lost before loading.
The difference was not significant (P = 0.33).
Clinical outcome
The mean probing pocket depth around
the implants did not significantly increase
between T5m and T16m (Table 2). Also, no
between-group differences in clinical parame-
ters plaque accumulation, bleeding tendency,
gingival index (Table 3) were observed.
Confounders
Compared with bone loss around single
implants, peri-implant bone loss was found
to be significantly (P = 0.001) higher when
two or more adjacent implants were placed.
The thought confounders implant location,
implant diameter, microbiological status,
mucosal thickness, and type of bone appar-
ently played no significant role.
Patient’s satisfaction
Feelings of shame and of visibility of being
partial edentulous clearly decreased as well
as that patient’s self-confidence increased
(Table 4). Patients were especially satisfied
about their increased ability to chew and
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about the color and the form of the crown.
No differences were observed between the
groups.
Discussion
This randomized clinical trial showed that
16 months after implant placement, peri-
implant bone loss was significantly less
around short implants provided with a plat-
form-switched implant–abutment connec-
tion, while with regard to implant survival,
clinical parameters, and patient’s satisfaction,
both implant–abutment connections showed
similar favorable results. A difference of
0.24 mm in radiographic bone preservation
might not be clinical relevant, but a reduc-
tion in bone resorption of 33% is interesting,
striving for perfection. The peri-implant bone
loss around platform-switched implants
resembled the peri-implant bone loss as
reported in the systematic review and meta-
analysis of Atieh et al. (2010) on longer
implants. In the control group, two patients
had a dehiscence and in the test group, one
patient had a dehiscence, which were in need
of GBR. No effect was shown when leaving
these implants out of statistical analysis of
peri-implant bone loss, so, also these
implants were included in the analysis.
Besides, Atieh et al. (2010) also did not
detect a statistically significant difference in
implant survival between the two platform
designs. Implant survival rates were lower
than the survival rates reported for 8.5 mm
implants (98.8%; 95% CI: 98.2–99.6%) in the
systematic review of Telleman et al. (2011a,
b). A reason for the lower survival rates in the
study could be the number of implants placed
in the maxilla as one of the conclusions of the
review to short implants was that the failure
rate of studies performed in the maxilla was
0.010 implants/year compared to 0.003 in the
mandible. Another reason might be due to the
fact that in the systematic review, also results
of studies were included in which short
implants could be splinted to longer implants.
And a reason could be that the implants used
had an extended platform for which the use of
countersink was needed for implant place-
ment, this might have led to less initial
implant stability (Renouard & Nisand 2006).
The platform-switched implants applied in
our trial had an implant–abutment diameter









(test group; n = 45)
Mean age ± SD and range (years) 50.2 ± 13.0 (18–70) 51.0 ± 10.4 (21–67)
Female/male ratio 39/8 38/7
Implant position
Maxillary (P1/P2/M1/M2) 31 (5/9/14/3) 31 (5/9/14/3)
Mandibular (P1/P2/M1/M2) 45 (4/17/19/5) 42 (2/15/20/5)






Microbiology (before implant placement)




Porphyromonas gingivalis > 0.0% 0 1
Prevotella intermedia > 2.5% 1 1
Bacteroides forsythus > 3.0% 1 0
Peptostreptococcus micros > 3.0% 7 4
Fusobacterium nucleatum > 3.0% 6 5
Combination of bacteria out of normal
range
5 10
Culture non-conclusive 7 7
Cause of tooth loss
Persistent apical periodontitis 17 13
Combined periodontic-endodontic lesion 1 0
Periodontal disease 7 7
Fracture 4 6
Dental caries 10 9
Congenitally missing tooth 4 3
Unknown 3 4











Guided bone regeneration applied 2 1


















Std. Dev. = .607245
N = 67
Platform-matched implant-abutment connection 
with a DAE-surface with CaP-particles























Std. Dev. = .530603
N = 70
Platform-switched implant-abutment connection 
with a DAE-surface with CaP-particles 
(a)
(b)
Figure 3. Frequency distributions of the mean peri-
implant bone loss of the 67 control (panel a) and 70 test
(panel b) implants. Both distributions differ significantly
from a normal distribution (blue curve).
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difference in horizontal dimension between
0.35 mm (implant diameter 4 mm) and
0.40 mm (implant diameter 5 mm). Atieh
et al. (2010) reported that subgroup analyses
showed that an implant–abutment differ-
ence  0.4 mm was associated with less
peri-implant bone loss (MD(0.4): 0.50; 95%
CI:0.72 to 0.29 in comparing to MD(<0.4):
0.10; 95% CI: 0.35 to 0.15). A bigger mis-
match is often caused, as in the current
study, by the use of a wider diameter. It has
been speculated that the findings of reduced
bone loss accompanying a larger implant–
abutment difference may be due to an
increased implant diameter rather than to the
platform (Enkling et al. 2011). But the study
of Canullo et al. (2011) on the impact of
implant diameter of platform-switched
implants clearly concluded no relation to
bone resorption. This difference could not be
found in the current RCT. Atieh et al. (2010),
however, did not consider the vertical dimen-
sion of the platform-switched implant–abut-
ment connection design, as most implant
systems have only a diameter difference in
horizontal dimension, resulting in a 90° angle
between implant and abutment. In the plat-
form-switched implants, we used the implant
–abutment connection that lies 0.09 mm
(implant diameter 4 mm) and 0.11 mm
(implant diameter 5 mm) above the outer-
most margin of the collar of the implant. So
when the platform-switched implants are
placed at crestal bone level, the implant–
abutment connection is slightly higher. From
the study of Cochran et al. (2009), we know
that the least bone resorption was shown
with the platform-switch situated 1 mm
above the alveolar crest. So, the design of our
platform-switched implants in vertical
dimension might have contributed to the
favorable results. Conversely, Veis et al.
(2010) reported the least bone resorption
when implants were placed subcrestally.
Obviously, from these contrasting results,
more comparative studies to the different
designs (in horizontal and vertical dimension)
and the level of placement of platform-
switched implants are needed.
It is clear from the current results that the
nanometer-sized deposition of CaP on the
DAE surface seems not to have an added
value on the survival rate of short implants
(8.5 mm in length) in the posterior zone.
Some in vivo animal studies found signifi-
cantly more bone response to surfaces with
particles of hydroxyapatite or CaP of different
nanosizes after 2–4 weeks (Meirelles et al.
2008b; Lin et al. 2009; Jimbo et al. 2011).
But other animal studies of maximum
6 weeks up to 3 months found no evidence
of better bone responses (Schliephake
et al. 2009; Vignoletti et al. 2009;
Schouten et al. 2010; Schwarz et al. 2010;
Svanborg et al. 2010). Human histologic and
histomorphometric studies of mini implants
placed in the posterior maxilla found after
4 weeks to 2 months showed significantly
more bone to implant and bone volume on
the surface with the nanoparticles CaP
(Goene´ et al. 2007; Orsini et al. 2007). One
study found after 3 months more old bone
particles on dual-acid etched surface with the
nanoparticles CaP as if a more active osteo-
genesis process was going on, which acceler-
ates the osseointegration process (Telleman
et al. 2010). Two prospective clinical studies
were reported on implants with a dual-acid
etched surface with nanoparticles CaP (O¨st-
man et al. 2010a,b). They concluded that the
nanoroughned surface performed compara-
tively well to other surfaces.
Overall patient’s satisfaction was high
in both groups. But this study was not pow-
ered to do a subgroup analysis on patients’
satisfaction, thus no conclusive conclusion
could be drawn.
Table 2. Changes in peri-implant bone level and pocket probing depths at implant and tooth sides from baseline to 16 months. Negative results in
implant bone-level changes indicate peri-implant bone loss and positive results in pocket probing depth changes indicate deepened peri-implant
pockets

















0.76 (±0.60)* 0.51 (±0.56)* 0.03 (±0.30) 0.02 (±0.30) 0.74 (±0.61)† 0.50 (±0.53)†

















0.42 (±0.56) 0.41 (±0.52) 0.02 (±0.24) 0.05 (±0.26) 0.36 (±0.53) 0.36 (±0.43)
Pocket probing depth changes (mm)
Implant – – 0.10 (±1.17) 0.09 (±0.66) 0.10 (±1.17) 0.09 (±0.66)
Tooth mesially of the
implant
0.06 (±0.53) 0.07 (±0.40) 0.02 (±0.52) 0.00 (±0.29) 0.06 (±0.48) 0.07 (±0.33)
Tooth distally of the implant 0.40 (±0.46) 0.17 (±0.88) 0.27 (±0.54) 0.13 (±0.65) 0.11 (±0.50) 0.03 (±0.52)

















0.85 (±0.58)‡ 0.56 (±0.57)‡ 0.05 (±0.31) 0.01 (±0.31) 0.82 (±0.60)§ 0.55 (±0.56)§
Pocket probing depth changes (mm)
Implant – – 0.24 (±0.62) 0.28 (±0.60) 0.24 (±0.62) 0.28 (±0.60)
Tooth mesially of the
implant
0.08 (±0.54) 0.04 (±0.58) 0.08 (±0.54) 0.16 (±0.51) 0.00 (±0.44) 0.17 (±0.68)
Tooth distally of the implant 0.50 (±0.66) 0.46 (±0.33) 0.75 (±0.79) 0.28 (±0.56) 0.50 (±0.79) 0.50 (±0.47)
For between-group comparisons: *P = 0.005, †P = 0.017, ‡P = 0.003, §P = 0.015.
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It is striking to see that even in the poster-
ior zone, patients experience feelings of
shame of being partially edentulous, because
the patients have the feeling that other peo-
ple can see they are missing a tooth or teeth.
With replacing this missing tooth or teeth, it
was obvious that their self-confidence
increased. This psychological distress was
also reported by the quality of life report in
partially edentulous patients by Nickenig
et al. (2008), who revealed 24.2% dissatisfac-
tion with appearance preoperative vs. 2.3%
postoperative. Patients were especially
satisfied about the ability to chew, the color
and the form of the crown and more indiffer-
ent about the color and the form of the
mucosa, as in the posterior region it is often
quite difficult to see the mucosa around the
crown.
In conclusion, for teeth replacements in
the resorbed posterior region of partially den-
Table 3. Clinical parameters of implants and adjacent teeth. No significant differences were found between control (platform-matched) and test
(platform-switched) group before (T0m), 1 month (T5m), and 1 year (T16m) in function in single or 2 or more adjacent implants placed
Clinical parameters
% at T0m % at T5m % at T16m
Platform-matched Platform-switched Platform-matched Platform-switched Platform-matched
Platform-
switched
Number of implants placed


























Score 0, no detection of
plaque
– – 84.2 90.2 84.6 90.7 84.2 70.6 91.7 75.9
Score 1, plaque on probe – – 15.8 9.8 15.4 9.3 15.8 21.6 0 14.8
Score 2, plaque seen by
naked eye
– – 0 0 0 0 0 7.8 0 9.3
Score 3, abundance of
soft matter
– – 0 0 0 0 0 0 0 0
Implant Bleeding Index*
Score 0, no bleeding – – 52.6 74.5 69.2 70.4 63.2 65.3 83.3 66.7
Score 1, isolated bleeding
spots
– – 42.1 25.5 30.8 29.6 36.8 32.7 16.7 29.6
Score 2, confluent line of
blood
– – 5.3 0 0 0 0 2.0 0 3.7
Score 3, heavy or profuse
bleeding
– – 0 0 0 0 0 0 0 0
Implant Gingival Index†
Score 0, normal mucosa – – 89.5 94.1 100 92.6 94.7 96.1 91.7 90.7
Score 1, mild inflammation – – 10.5 5.9 0 7.4 5.3 3.9 8.3 9.3
Score 2, moderate
inflammation
– – 0 0 0 0 0 0 0
Score 3, severe
inflammation
– – 0 0 0 0 0 0 0
Implant dental calculus
Score 0, no dental calculus – – 100 100 100 100 100 100 100 100
Score 1, dental calculus
present
– – 0 0 0 0 0 0 0 0
Adjacent teeth Plaque index*
Score 0, no detection of
plaque
50.0 66.7 73.7 65.7 76.5 93.9 88.0 78.1 85.3 88.2 91.3 90.9
Score 1, plaque on probe 41.2 33.3 23.7 34.3 23.5 6.1 12.0 18.8 14.7 8.8 8.7 9.1
Score 2, plaque seen by
naked eye
8.8 0 2.6 0 0 0 0 3.1 0 2.9 0 0
Score 3, abundance of soft
matter
0 0 0 0 0 0 0 0 0 0 0 0
Adjacent teeth Bleeding index*
Score 0, no bleeding 76.5 77.8 76.3 80.0 82.4 90.9 88.0 84.4 94.1 88.6 100 97.0
Score 1, isolated bleeding
spots
20.6 22.2 23.7 17.1 17.6 9.1 12.0 15.6 5.9 11.4 0 3.0
Score 2, confluent line of
blood
2.9 0 0 2.9 0 0 0 0 0 0 0 0
Score 3, heavy or profuse
bleeding
0 0 0 0 0 0 0 0 0 0 0 0
Adjacent teeth Gingival Index†
Score 0, normal mucosa 91.2 91.7 100 94.3 100 93.9 100 100 100 100 100 100
Score 1, mild inflammation 8.8 8.3 0 5.7 0 6.1 0 0 0 0 0 0
Score 2, moderate
inflammation
0 0 0 0 0 0 0 0 0 0 0 0
Score 3, severe inflammation 0 0 0 0 0 0 0 0 0 0 0 0
Adjacent teeth dental calculus
Score 0, no dental calculus 88.2 88.9 92.1 94.3 91.2 93.9 92.0 93.8 94.1 100 100 91.2
Score 1, dental calculus
present
11.8 11.1 7.9 5.7 8.8 6.1 8.0 6.3 5.9 0 0 8.8
*Mombelli et al. (1987).
†Lo¨e & Silness (1963).
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tate patients, short implants (8.5 mm in
length) with a platform-switched implant–
abutment connection showed significantly
less peri-implant bone loss after 1 year in
function, while implant survival, clinical
parameters, and patient’s satisfaction were
independent of the implant–abutment con-
nection design.
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